JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Others

B8015 ML216

Target: BLM

Summary: BLM helicase inhibitor

insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
B4857 YL-109

Summary: novel anticancer agent

insoluble in H2O; ≥11.4 mg/mL
B6008 BPTES

Target: Glutaminases

Summary: GLS inhibitor

insoluble in H2O; insoluble in EtOH; ≥18 mg/mL
B6018 Disodium (R)-2-Hydroxyglutarate

Summary: inhibitor of α-ketoglutarate-dependent dioxygenases

insoluble in EtOH; insoluble in DMSO; ≥9.1 mg/mL
B1051 GSK 650394
2 Citation

Target: SGK

Summary: SGK1 inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.1 mg/mL
B1306 KN-93 hydrochloride

Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)

Summary: CaMK II inhibitor

≥26.9 mg/mL
B1309 GNE-617 hydrochloride

Target: Nampt

Summary: NAMPT inhibitor, potent and competitive

Soluble in DMSO
B1373 Phenformin HCl
1 Citation

Target: AMPK

Summary: biguanidine drug with anti-diabetic activity

≥12.1 mg/mL
B1036 MLN4924
5 Citation

Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation

Summary: NAE inhibitor

≥22.18 mg/mL
B1858 Tranexamic Acid

Target: fibrinolysis

Summary: competitive inhibitor of plasminogen activation

insoluble in EtOH; insoluble in DMSO; ≥6.6 mg/mL